Publications by authors named "Yoko Narikawa-Shiono"

Importance: Mammography has limited accuracy in breast cancer screening. Ultrasonography, when used in conjunction with mammography screening, is helpful to detect early-stage and invasive cancers for asymptomatic women with dense and nondense breasts.

Objective: To evaluate the performance of adjunctive ultrasonography with mammography for breast cancer screening, according to differences in breast density.

View Article and Find Full Text PDF

Background: Mammography is the only proven method for breast cancer screening that reduces mortality, although it is inaccurate in young women or women with dense breasts. We investigated the efficacy of adjunctive ultrasonography.

Methods: Between July, 2007, and March, 2011, we enrolled asymptomatic women aged 40-49 years at 42 study sites in 23 prefectures into the Japan Strategic Anti-cancer Randomized Trial (J-START).

View Article and Find Full Text PDF

Background: It is often difficult to enrol healthy volunteers into a randomized controlled trial (RCT) as there are barriers to participants' proper understanding of a trial. This study aimed to evaluate degrees of understanding of the informed consent (IC) process among healthy volunteers who participated in an RCT. Additionally, factors associated with degree of understanding were investigated.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Yoko Narikawa-Shiono"

  • - Yoko Narikawa-Shiono's research primarily focuses on improving breast cancer screening methods, particularly the integration of adjunctive ultrasonography with traditional mammography in women aged 40-49, with varying breast densities.
  • - Her studies demonstrate that using ultrasonography alongside mammography enhances the detection of early-stage and invasive breast cancers, addressing the limitations of mammography alone, especially in women with dense breast tissue.
  • - Additionally, Narikawa-Shiono investigates participant comprehension of informed consent processes in randomized controlled trials (RCTs), emphasizing the importance of clear communication to ensure appropriate understanding and enrollment of volunteers in breast cancer screening trials.